Hair Loss Alopecia
An Advanced Solution For Growing Hair
PRP therapy for hair loss is a new non-surgical option for natural hair growth and stimulation and it is been considered the best medical treatment for hair loss since Propecia.
The procedure is very simple and it is completely done at our office in approximately 45 minutes. We first draw your own blood(like on a blood lab sample), centrifuge the blood to separate the platelets, activate these platelet with chemical agents and then inject it in the areas of hair loss concern. The treatment is complemented with an in home use of a prescribed shampoo, lotion, and pills. The initial protocol consist of 3 PRP sessions and 3 Injection sessions of vitamins. We do a follow up visit 3 months after the last session to determine the improvement on hair density and growth.
Call for your free consultation and our Health Care Providers will explain in detail the best protocol that works for you.
Using EX-H Shot dermal fibroblast exosomes and growth factors as a treatment for hair loss has shown prominent hair growth results in both men and women. It’s highly recommended for those who are too young for hair transplant surgery and for those within the earlier stages of the hair loss cycle.
EX-H Shot Exosome Hair Therapy may begin promoting natural hair growth in as little as two to three months.
New hair growth can continue over the course of a year, with the most noticeable results usually being seen six months after treatment has been administered. The new hair growth can provide patients with natural, thicker and fuller results. The EX-H Shot and PRP are often combined together to gain even more profound results.
- Isolating the beneficial signals given out by stem cells and using them, rather than the stem cells themselves, is the next generation of therapy.
- Other cells will react to these messaging signals and will change their behavior accordingly. There is a tremendous therapeutic potential for extracellular vesicles, particularly exosomes.
- EX-H Shot exosomes are derived from dermal stem cells.
A century of history has been documented with no reported recipient rejections because the amniotic tissue does no express HLA type antigens. In fact, there is a significant body of peer-reviewed literature documenting anti-microbial, anti-inflammatory, and anti-tumorigenic characteristics. Additionally, the literature demonstrates up-regulation of healthy, strong tissue regeneration.